Seasonally weak quarter, but 2025 guidance firm '25e-'27e adj.
With its third attempt to scale offline payments in India, Crunchfish hopes that its new Offline Ter...
Ahead of Solwers' Q1 2025 report, we cut our EBIT estimates by 9-11% for 2025-27 as we expect a some...
Redeye comments on Friday evening’s news from Dala Energi’s AGM, where the voluntary share redemptio...
6% organic sales growth y-o-y SaaS momentum drives gross margin uplift.
Redeye comments on Faron’s recent publication in a scientific journal, which provides valuable mecha...
Adj. EBITDA 35% above, but boosted by one-offs in Senior Soft watch sales, but volumes will shift to...
Redeye updates on GiG after Q1-results which were in line with our expectations and we leave our est...
Redeye’s forecasts and valuation remain unchanged following today’s announced outcome of the TO3 war...
Redeye comments on Cinclus Pharma’s announcement earlier today of a EUR220m licensing agreement with...
Redeye comments on the intriguing data from the phase I/II CARMA-study presented by Elicera this mor...
Redeye comments on Jumpgate’s Q1 2025 report, which contained no major surprises and delivered a top...
Redeye shares its initial take on Genovis following the Q1 report, which delivered sales 13% above o...
Redeye comments on Embracer’s Q4-results which saw stronger-than-expected EBIT, driven by PC/Console...
Redeye comments on Better Collective’s Q1-results which were somewhat better than expected as revenu...
